PHR Stock Analysis: Buy, Sell, or Hold?
PHR - Phreesia, Inc.
$12.12
0.12 (1.00%)
â˛
5d:
-1.3%
30d:
+23.67%
90d:
+38.04%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Sep 02, 2026
9d
Get Alerted When PHR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: PHR is fairly priced but lacks strong directional signals. At -4.5% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: PHR is fairly priced but lacks strong directional signals. At -4.5% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$26.98
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$16.75
27.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PHR is currently trading at $12.12, which is considered slightly high relative to its 30-day fair value range of $10.46 to $11.99. From a valuation perspective, the stock is trading at a discount (Forward PE: 8.0) compared to its historical average (9.2). Remarkably, the market is currently pricing in an annual earnings decline of 4.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, PHR is in a strong uptrend. Immediate support is located at $11.26, while resistance sits at $12.69.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $13.94 (+16.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PHR is in a strong uptrend. Immediate support is located at $11.26, while resistance sits at $12.69.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $13.94 (+16.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$10.46 -
$11.99
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
62.9%
Protect Your Profits
Holding PHR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Mixed technical signals (42/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($13.94)
- WARNING: Composite score 51/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$10.46 -
$11.99
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$11.26
Resistance Level
$12.69
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.97
Wall Street Target
$13.94
(+16.2%)
Revenue Growth (YoY)
12.9%
Profit Margin
1.8%
Valuation Discount vs History
-4.5% cheaper
PE vs Historical
8.0 vs 9.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.5%
(market-implied from PE analysis)
1-Year Target
$11.46
(-5%)
2-Year Target
$10.94
(-9%)
3-Year Target
$10.45
(-13%)
3-Yr Target (if PE normalizes)
(PE: 8â9)
$12.07
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 29.2%)
$65.11
(+443%)
Base:
(SPY PE: 8.0, Growth: 29.2%)
$25.85
(+115%)
Bear:
(PE: 6.8, Growth: 29.2%)
$21.97
(+83%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (15x PE), but valuation improves significantly next year (8x PE) as earnings recover.
Forward PE: 15.24 | Forward EPS (Implied): $0.80
Bull Case
$14.63
(+21%)
Analyst growth 15.0%, PE expands to 16.0
Base Case
$12.12
(0%)
Market implied 0.0%, PE stable at 15.2
Bear Case
$9.27
(-24%)
Severe decline -15.0%, PE contracts to 13.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.0 to 9.2
Stabilization Target:
$13.85
(+15.5%)
PE Expansion Potential:
+15.5%
Share & Embed Analysis
Last updated: August 23, 2026 4:15 PM ET
Data refreshes hourly during market hours. Next update: 5:15 PM
Data refreshes hourly during market hours. Next update: 5:15 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PHR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Allison C Hoffman
SELL
6176 shares
2026-04-20
Yvonne Hui
SELL
1327 shares
2026-04-17
Yvonne Hui
SELL
10063 shares
2026-04-16
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 50 HOLD |
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$254 | 33 SELL |
|
GEHC
GE HealthCare TechnologiâĻ |
STRONG BUY
21 analysts |
$90 | 37 SELL |
|
BTSG
BrightSpring Health ServâĻ |
STRONG BUY
12 analysts |
$79 | 63 BUY |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 41 HOLD |
Advanced PHR Option Strategies
Professional options setups generated by AI based on today's PHR price and gamma walls.
